AFP and hepatocellular carcinoma: Additionally, they also demonstrated a paper-based lateral flow fluorescence immunoassay (LFIA), using MAFs for the effective detection of alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma.